"Designing Growth Strategies is in our DNA"
Antibacterial drugs are the compounds that are used against the bacteria which work by either inhibiting their growth of by killing them. Many classes of antibacterial drugs have been developed and are available according to their chemical nature, range of activity, and method of action. An increase in the incidences of infectious diseases resulting in the rise in the demand for antibacterial drugs is driving the market growth. Factors such as a rise in incidences of infectious diseases, growing healthcare spending, modernization of the healthacre infrastructure, and improving diagnosis rate are the major factor driving the growth of the market. According to the World Health Organization (WHO), more than 30 new infections have been estimated to have emerged in the last two decades, which threaten the health of millions of individuals.
Moreover, an increase in the frequencies of zoonotic diseases is also propelling the growth of the market. According to the Centers for Disease Control (CDC) in 2017, estimated that 3/4th of new or emergent infectious diseases in society come from animals. In addition, the growth of the market is also expected to be boosted by the multidrug-resistant bacteria known as superbugs. The overall growth of the market is rising due to factors such as significant investments in R&D activities, a rise in the incidences of infectious diseases, and zoonotic disease outbreaks.
However, stringent regulatory guidelines, resistance to the antibacterial drugs developed bt the bacterias, and high cost of drug approval are projected to obstruct the market growth.
Key Market Driver -
Rise in incidences of infectious diseases and zoonotic diseases.
Key Market Restraint -
Stringent regulatory guidelines and high cost of drug approval.
The global antibacterial drugs market can be segmented on the basis of class, route of administration, distribution channel, and region. Based on the class, the market can be segmented into B – lactams, tetracycline, quinolones, macrolides, sulfonamide, and others. Based on the route of administration, the market can be segmented into oral and parenteral. Based on the distribution channel, the market can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies
Geographically, the antibacterial drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The major companies in the global antibacterial drugs report include Shionogi & Co., Ltd., Bayer AG, Pfizer Inc., Sanofi, GlaxoSmithKline plc., Merck & Co., Inc., AstraZeneca, Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Novartis AG, Allergan, and other prominent players.
Geographically, the global antibacterial drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Geographically, North America is expected to account for the significant market share of the market, and it is also anticipated to retain its superiority throughout the forecast period. The region will prove to be a profitable market for antibacterial drug manufacturers due to enormous R&D expenditure and developing treatment solutions for superbugs. Europe's market is anticipated to holds the second-largest share in the market. However, Asia-Pacific possesses the high potential for growth of the market due to the rise in the geriatric population, an increase in the incidences of infectious & zoonotic diseases, growing R&D activities in this region as well as growing demand for improved antibacterial drugs at an affordable cost in the region. Latin America and the Middle East & Africa are increasing steadily in the market.
To gain extensive insights into the market, Request for Customization
By Route of Administration
By Distribution Channel
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry